PPD, Charité–Universitätsmedizin Berlin collaborate

Friday, February 21, 2014

Pharmaceutical Product Development (PPD) and the CharitéUniversitätsmedizin Berlin have formed a new collaboration between the company and the hospital’s clinical trials management unit (CTMU) to increase the volume of clinical trials conducted in Germany, improve access to commercial clinical research for patients, accelerate the development of new medicines and enhance health care treatment opportunities for German citizens.

[Read More]

BI, EFSD commit $3.3 million to European diabetes research initiatives

Friday, July 19, 2013

The Boehringer Ingelheim (BI) and European Foundation for the Study of Diabetes (EFSD) partnership has announced the recipients of its European-wide funding initiative targeted at diabetes research. Totaling $3.3 million, these are the first grants to be awarded as part of the EFSD/Boehringer Ingelheim European Diabetes Research Programs, which aim to stimulate and accelerate European research in diabetes.

[Read More]